 |
angiotensin 1-7 |
|---|---|
| Trade Name | |
| Orphan Indication | To accelerate engraftment of hematopoietic cells (treatment of neutropenia, thrombocytopenia, lymphoma, and aneima)in hematopoietic stem cell transplants |
| USA Market Approval | USA |
| USA Designation Date | 2010-06-17 00:00:00 |
| Sponsor | Tarix Pharmaceuticals, Ltd.;12 Bow Street;Cambridge, Massachusetts, 02138 |
